| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2012 | US20120022079 Method For Producing Preparations Of Substances Poorly Soluble In Water |
| 01/26/2012 | US20120022078 Aryl indole derivatives |
| 01/26/2012 | US20120022077 Novel cyanopyrimidine derivative |
| 01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
| 01/26/2012 | US20120022075 Novel phenylpyrrole derivative |
| 01/26/2012 | US20120022074 Organic compounds |
| 01/26/2012 | US20120022073 Compound for the treatment of enteroviruses |
| 01/26/2012 | US20120022072 Pterin analogs |
| 01/26/2012 | US20120022071 Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction |
| 01/26/2012 | US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use |
| 01/26/2012 | US20120022069 Acrylamide compounds and the use thereof |
| 01/26/2012 | US20120022068 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 01/26/2012 | US20120022067 Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/26/2012 | US20120022065 C-Met Modulators and Method of Use |
| 01/26/2012 | US20120022064 Dihydroquinolinone derivatives |
| 01/26/2012 | US20120022063 Oligomer-Cannabinoid Conjugates |
| 01/26/2012 | US20120022062 Flavanoid Compounds and Process for Preparation Thereof |
| 01/26/2012 | US20120022061 Benzo [c] phenanthridines as antimicrobial agents |
| 01/26/2012 | US20120022060 Tricyclic Azaindoles |
| 01/26/2012 | US20120022059 Substituted furancarboxamides, and use thereof |
| 01/26/2012 | US20120022058 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| 01/26/2012 | US20120022057 Bicyclic compounds as inhibitors of diacyglycerol acyltransferase |
| 01/26/2012 | US20120022056 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 01/26/2012 | US20120022054 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents |
| 01/26/2012 | US20120022052 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 01/26/2012 | US20120022051 Rapid onset liquid midazolam composition for buccal administration |
| 01/26/2012 | US20120022050 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 01/26/2012 | US20120022049 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 01/26/2012 | US20120022048 Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth |
| 01/26/2012 | US20120022047 Process for the purification of eslicarbazepine acetate |
| 01/26/2012 | US20120022046 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| 01/26/2012 | US20120022045 Bridged compounds as hiv integrase inhibitors |
| 01/26/2012 | US20120022044 Triazole derivatives for treatment of alzheimer's disease |
| 01/26/2012 | US20120022043 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/26/2012 | US20120022042 Carbocyclic glyt1 receptor antagonists |
| 01/26/2012 | US20120022041 Substituted heterocyclic compounds |
| 01/26/2012 | US20120022040 Antimicrobials |
| 01/26/2012 | US20120022039 Novel substituted indanes, method for the production thereof, and use thereof as drugs |
| 01/26/2012 | US20120022038 Animal treatment formulation and methods of use |
| 01/26/2012 | US20120022037 Aqueous hair cleansing agent |
| 01/26/2012 | US20120022036 Method of treating osteoporosis |
| 01/26/2012 | US20120022035 Polymorphic and Amorphous Salt Forms of Squalamine Dilactate |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120022033 Methods for decreasing cardiovascular risk in postmenopausal women |
| 01/26/2012 | US20120022032 Corticosteroid compositions and methods of treatments thereof |
| 01/26/2012 | US20120022031 Composition and methods of treatment of bacterial meningitis |
| 01/26/2012 | US20120022030 Tetracyclic Lactame Derivatives |
| 01/26/2012 | US20120022029 Topical pain reliever and method of making the same |
| 01/26/2012 | US20120022028 Sgc stimulators or sgc activators in combination with pde5 inhibitors for the treatment of erectile dysfunction |
| 01/26/2012 | US20120022027 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 01/26/2012 | US20120022026 Method of treating cancer |
| 01/26/2012 | US20120022025 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 01/26/2012 | US20120022024 Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus |
| 01/26/2012 | US20120022023 Hydraulic Cements, Methods and Products |
| 01/26/2012 | US20120022022 Novel inhibitors of chymase |
| 01/26/2012 | US20120022020 Pharmaceutical forms for the release of active compounds |
| 01/26/2012 | US20120022019 Medicinal Steroids Cream And A Process To Make It |
| 01/26/2012 | US20120022018 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 01/26/2012 | US20120022017 Composition and a method thereof |
| 01/26/2012 | US20120022016 Compounds and methods for selectively targeting tumor-associated mucins |
| 01/26/2012 | US20120022015 Method of treatment and supplement |
| 01/26/2012 | US20120022014 Tetrahydropyran nucleic acid analogs |
| 01/26/2012 | US20120022013 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 01/26/2012 | US20120022012 Glycosylated Acetaminophen Pro-Drug Analogs |
| 01/26/2012 | US20120022011 Hsp90 inhibitors with modified toxicity |
| 01/26/2012 | US20120022010 Use of flavonoids to increase the bioavailability of hesperetin |
| 01/26/2012 | US20120022009 Tannate dry powder formulations |
| 01/26/2012 | US20120022007 Method and composition for modulating canonical wnt pathway using folate and inositol |
| 01/26/2012 | US20120022004 Treatment of t-cell mediated diseases |
| 01/26/2012 | US20120022003 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022002 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | US20120022001 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
| 01/26/2012 | US20120021997 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021996 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021994 Novel cancer antigen eef2 |
| 01/26/2012 | US20120021989 Genetic markers for risk management of atrial fibrillation and stroke |
| 01/26/2012 | US20120021986 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 01/26/2012 | US20120021981 Compositions to prevent and treat type-1 diabetes |
| 01/26/2012 | US20120021979 GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction |
| 01/26/2012 | US20120021976 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders |
| 01/26/2012 | US20120021968 Methods for treating or preventing urological inflammation |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120021078 nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children |
| 01/26/2012 | US20120021074 P2x3, receptor antagonists for treatment of pain |
| 01/26/2012 | US20120021073 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox |
| 01/26/2012 | US20120021072 Compositions For The Treatment And Prevention Of Eyelid Swelling |
| 01/26/2012 | US20120021057 Once-daily oral ir/cr pramipexole formulation |
| 01/26/2012 | US20120021055 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 01/26/2012 | US20120021053 Controlled release and taste-masking oral pharmaceutical composition |
| 01/26/2012 | US20120021052 Controlled release and taste masking oral pharmaceutical composition |
| 01/26/2012 | US20120021051 Zaleplon gastroretentive drug delivery system |
| 01/26/2012 | US20120021050 Nanoparticle formulated glycolipid antigens for immunotherapy |
| 01/26/2012 | US20120021049 Single Daily Dosage Form for Prevention and Treatment of Metabolic Syndrome |
| 01/26/2012 | US20120021048 Combination Dosage Compositions Comprising a Cholesterol-Lowering Agent, a Renin-Angiotensin System Inhibitor, an Antioxidant Agent and an Antiplatelet Agent for Treatment and Prevention of Cardiovascular Disease |
| 01/26/2012 | US20120021047 Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 01/26/2012 | US20120021046 Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods |
| 01/26/2012 | US20120021044 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same |
| 01/26/2012 | US20120021042 Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances |
| 01/26/2012 | US20120021041 Transdermal delivery |
| 01/26/2012 | US20120021038 Coating composition |